澳大利亚炎症性肠病关于孕前、妊娠及哺乳期的共识声明
该共识采用改良RAND/UCLA appropriateness方法制定,由多学科工作组通过文献回顾、在线投票、讨论会及第二轮投票形成,就炎症性肠病患者妊娠期管理达成38/39条声明一致。声明强调多数药物可且应在整个妊娠期继续使用,但甲氨蝶呤、别嘌醇及托法替布等新型小分子药物除外;因数据有限,尚未对妊娠期使用硫鸟嘌呤得出结论。
要点
- 多数药物可且应在整个妊娠期继续使用,但甲氨蝶呤、别嘌醇及托法替布等新型小分子药物除外。
- 孕前及整个妊娠期达到并维持炎症性肠病缓解对优化母婴结局至关重要。
- 妊娠期可使用肠道超声监测疾病,临床必要时可行软式乙状结肠镜检查或MRI。
核心结论
- 该共识声明为炎症性肠病患者妊娠期管理提供了最新、全面的推荐,旨在使所有临床环境中的患者获得高标准诊疗。
研究设计与样本
- 成立多学科工作组制定共识声明,采用改良RAND/UCLA appropriateness方法,包括文献回顾、在线投票、讨论会及第二轮投票。
- 报告了代表间的总体同意程度及声明的适当性。
主要发现
- 就39条声明中的38条达成一致,为炎症性肠病患者妊娠期管理提供指导。
- 多数药物可且应在整个妊娠期继续使用,但甲氨蝶呤、别嘌醇及托法替布等新型小分子药物除外。
- 因数据有限,尚未对妊娠期使用硫鸟嘌呤得出结论。
- 孕前及整个妊娠期达到并维持炎症性肠病缓解对优化母婴结局至关重要。
- 妊娠期可使用肠道超声监测疾病,临床必要时可行软式乙状结肠镜检查或MRI。
关键数值与推荐
- 39条声明中38条达成一致。
- 多数药物可且应在整个妊娠期继续使用,但甲氨蝶呤、别嘌醇及托法替布等新型小分子药物除外。
- 因数据有限,尚未对妊娠期使用硫鸟嘌呤得出结论。
临床怎么用
- 需要多学科方法使患者参与、减轻焦虑并最大化药物依从性。
- 妊娠期可使用肠道超声监测疾病,临床必要时可行软式乙状结肠镜检查或MRI。
局限性
- 因数据有限,尚未对妊娠期使用硫鸟嘌呤得出结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Because pregnancy outcomes tend to be worse in women with inflammatory bowel disease (IBD) than in those without, we aimed to update consensus statements that guide the clinical management of pregnancy in patients with IBD. DESIGN: A multidisciplinary working group was established to formulate these consensus statements. A modified RAND/UCLA appropriateness method was used, consisting of a literature review, online voting, discussion meeting and a second round of voting. The overall agreement among the delegates and appropriateness of the statement are reported. RESULTS: Agreement was reached for 38/39 statements which provide guidance on management of pregnancy in patients with IBD. Most medications can and should be continued throughout pregnancy, except for methotrexate, allopurinol and new small molecules, such as tofacitinib. Due to limited data, no conclusion was reached on the use of tioguanine during pregnancy. Achieving and maintaining IBD remission before conception and throughout pregnancy is crucial to optimise maternofetal outcomes. This requires a multidisciplinary approach to engage patients, allay anxieties and maximise adherence tomedication. Intestinal ultrasound can be used for disease monitoring during pregnancy, and flexible sigmoidoscopy or MRI where clinically necessary. CONCLUSION: These consensus statements provide up-to-date, comprehensive recommendations for the management of pregnancy in patients with IBD. This will enable a high standard of care for patients with IBD across all clinical settings.
引用
- Laube R, Selinger CP, Seow CH, et al. Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut. 2023. PMID: 36944479. doi:10.1136/gutjnl-2022-329304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。